Skip to search formSkip to main contentSkip to account menu

candesartan cilexetil 32 MG / Hydrochlorothiazide 25 MG Oral Tablet

Known as: CANDESARTAN CILEXETIL 32 mg / HYDROCHLOROTHIAZIDE 25 mg ORAL TABLET [Candesartan Cilexetil-Hydrochlorothiazide], candesartan cilexetil 32 MG / HCTZ 25 MG Oral Tablet, CANDESARTAN CILEXETIL 32MG/HYDROCHLOROTHIAZIDE 25MG TAB 
National Institutes of Health

Related topics

Related topics

18 relations
CARBOXYMETHYLCELLULOSE CALCIUMGlycerinHydrochlorothiazideHydrochlorothiazide 25 MG

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Auswirkungen einer Langzeit-Candesartan/Hydrochlorthiazid-Einnahme in der Schwangerschaft – ein Fallbericht
2017
2017
Oral solid self-nanoemulsifying drug delivery systems of candesartan citexetil: formulation, characterization and in vitro drug release studies
Candesartan cilexetil is an ester prodrug antagonist to angiotensin II receptor type 1 (AT1) used in management of many… 
2016
2016
DEVELOPMENT OF SOLID LIPID NANOCARRIERS FOR ORAL DELIVERY OF CANDESERTAN CILEXETIL.
Candesertan cilexetil is a Biopharmaceutics Classification System (BCS) Class II drug possessing high permeability but low… 
2016
2016
ATACAND HCT 16-12.5 (candesartan cilexetil−hydrochlorothiazide) TABLETS, FOR ORAL USE ATACAND HCT 32-12.5 (candesartan cilexetil−hydrochlorothiazide) TABLETS, FOR ORAL USE ATACAND HCT 32–25…
  • 2016
  • Corpus ID: 29331719
2014
2014
FORMULATION AND EVALUATION OF SUBLINGUAL TABLET OF CANDESARTAN CILEXETIL
Candesartan Cilexetil is a non-peptide angiotensin II type-1 (AT1) receptor antagonist used in the treatment of Hypertention… 
2012
2012
Specific and Stability Indicating Assay Method of Cadesartan Cilexetil in Presence of Process and Degradation Impurities
Candesartan is used for the treatment of hypertension and works as angiotensin II receptor antagonists. In the presented paper a… 
2008
2008
Graphical Synthetic Routes of Candesartan Celexicitil
2005
2005
Evaluation of the effect of candesartan cilexetil on the steady-state pharmacokinetics of tacrolimus in renal transplant patients.
BACKGROUND Candesartan cilexetil is a possible treatment for hypertension in renal allograft recipients. Tacrolimus is widely… 
2004
2004
Candesartan bij hartfalen
Patienten met chronisch hartfalen hebben een grotere kans op ziekenhuisopname en overlijden door een cardiale oorzaak. Voor… 
Review
2002
Review
2002
[Ameliorative effects on retinal disorder in diabetic SHRSP (stroke-prone spontaneously hypertensive rat)].
The results of the EUCLID highlighted the importance of the renin-angiotensin system in the pathogenesis of diabetic retinopathy… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)